e-Seminars where Early Stage Researchers have

e- Seminar One – Tuesday 18th February 2020

“The Role of microglia in neurodegenerative diseases”

presented by George Sideris-Lampretsas ESR1

Review by Fátima Gimeno-Ferrer  ESR8

ESR 11 Neuroinflammation and CNS hyper-excitability in chronic pain and neurodegeneration

e-Seminar One A – Tuesday 24th March 2020

“Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease” presented by Joana Lama ESR2

Review by Cristiana Dumbraveanu ESR10

Role of microglia and macrophages and the CX3CL1-CX3CR1 pathway in arthritis-induced pain

e-Seminar Two – Friday 6th November 2020

“Central sensitisation in Rheumatic diseases”

presented by Zerina Kurtovic ESR5

and Silvia Fanton ESR3

Review by Joana Menezes ESR4

Assessment of medical marijuana bioactive substances in a mouse model of neuropathic pain

e-Seminar Three – April 2021

“Response of immune cells in neuropathic pain”

presented by

Jeiny Luna-Choconta ESR6 and

Cristiana Dumbraveanu ESR10

Review by Anutosh Roy ESR7

been trained ‘to critically evaluate’ a theory or findings

Mechanisms of spinal neuroinflammation and hyperexcitability in models of joint inflammation

e-Seminar Four A – September 2021

“Peripheral sensitization in chronic pain”

presented by Anutosh Roy ESR7

Review by Silvia Fanton

Impact of neuroinflammation and neurodegeneration on brain and spinal cord

e-Seminar Four B – October 2021

‘Emerging role of Schwann Cells in Neuropathic Pain: Receptors, Glia Mediators and Myelination’

presented by Fátima Gimeno-Ferrer  ESR8

Review by Jeiny Luna-Choconta ESR6

e-Seminar Four C  – October 2021

“Tumor necrosis factor receptor-1 is selectively sequestered into Schwann cell extracellular vesicles where it functions as a TNF alpha decoy”

Paper by Sadri et al. published in Glia

presented by

Patricia Laura García Fernández ESR9

Review by Zerina Kurtovic ESR5

Eu flag logo blue and yellow

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Grant Agreement No 764860.